| Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease N Sabaa, L De Franceschi, P Bonnin, Y Castier, G Malpeli, H Debbabi, ... The Journal of clinical investigation 118 (5), 1924-1933, 2008 | 159 | 2008 |
| Targeting cancer stem cells to overcome chemoresistance T Nunes, D Hamdan, C Leboeuf, M El Bouchtaoui, G Gapihan, TT Nguyen, ... International journal of molecular sciences 19 (12), 4036, 2018 | 146 | 2018 |
| Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression WL Zhao, S Mourah, N Mounier, C Leboeuf, ME Daneshpouy, L Legrès, ... Laboratory investigation 84 (11), 1512-1519, 2004 | 146 | 2004 |
| A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk MJ Redondo, S Geyer, AK Steck, S Sharp, JM Wentworth, MN Weedon, ... Diabetes care 41 (9), 1887-1894, 2018 | 144 | 2018 |
| Th17/Treg ratio in human graft-versus-host disease P Ratajczak, A Janin, R Peffault de Latour, C Leboeuf, A Desveaux, ... Blood, The Journal of the American Society of Hematology 116 (7), 1165-1171, 2010 | 125 | 2010 |
| Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma WL Zhao, ME Daneshpouy, N Mounier, J Brière, C Leboeuf, LF Plassa, ... Blood 103 (2), 695-697, 2004 | 90 | 2004 |
| Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified MM Ji, YH Huang, JY Huang, ZF Wang, D Fu, H Liu, F Liu, C Leboeuf, ... Haematologica 103 (4), 679, 2018 | 89 | 2018 |
| BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia N Omidvar, S Kogan, S Beurlet, C le Pogam, A Janin, R West, ... Cancer research 67 (24), 11657-11667, 2007 | 85 | 2007 |
| Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease M Ertault-Daneshpouy, C Leboeuf, M Lemann, F Bouhidel, L Ades, ... Blood 103 (12), 4681-4684, 2004 | 84 | 2004 |
| Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation A Janin, H Murata, C Leboeuf, JM Cayuela, E Gluckman, L Legres, ... Blood, The Journal of the American Society of Hematology 113 (8), 1834-1840, 2009 | 79 | 2009 |
| Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma YY Liu, C Leboeuf, JY Shi, JM Li, L Wang, Y Shen, JF Garcia, ZX Shen, ... Blood, The Journal of the American Society of Hematology 110 (1), 339-344, 2007 | 74 | 2007 |
| In vivo Distribution of Inorganic Nanoparticles in Preclinical Models M Varna, P Ratajczak, I Ferreira, C Leboeuf, G Bousquet, A Janin Scientific Research Publishing, 2012 | 73 | 2012 |
| Donor-derived cells and human graft-versus-host disease of the skin H Murata, A Janin, C Leboeuf, J Soulier, E Gluckman, V Meignin, G Socie Blood 109 (6), 2663-2665, 2007 | 72 | 2007 |
| p53 dependent cell‐cycle arrest triggered by chemotherapy in xenografted breast tumors M Varna, J Lehmann‐Che, E Turpin, E Marangoni, M El‐Bouchtaoui, ... International journal of cancer 124 (4), 991-997, 2009 | 65 | 2009 |
| The interplay between peroxiredoxin-2 and nuclear factor-erythroid 2 is important in limiting oxidative mediated dysfunction in β-thalassemic erythropoiesis A Matte, L De Falco, A Iolascon, N Mohandas, X An, A Siciliano, ... Antioxidants & redox signaling 23 (16), 1284-1297, 2015 | 64 | 2015 |
| PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor WL Zhao, YY Liu, QL Zhang, L Wang, C Leboeuf, YW Zhang, J Ma, ... Blood, The Journal of the American Society of Hematology 111 (7), 3867-3871, 2008 | 61 | 2008 |
| Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer G Bousquet, M El Bouchtaoui, T Sophie, C Leboeuf, C de Bazelaire, ... Oncotarget 8 (21), 35205, 2017 | 60 | 2017 |
| BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells S Beurlet, N Omidvar, P Gorombei, P Krief, C Le Pogam, N Setterblad, ... Blood, The Journal of the American Society of Hematology 122 (16), 2864-2876, 2013 | 59 | 2013 |
| Stem cells increase in numbers in perinecrotic areas in human renal cancer M Varna, G Gapihan, JP Feugeas, P Ratajczak, S Tan, I Ferreira, ... Clinical cancer research 21 (4), 916-924, 2015 | 56 | 2015 |
| The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model A Matte, E Federti, C Kung, PA Kosinski, R Narayanaswamy, R Russo, ... The Journal of clinical investigation 131 (10), 2021 | 55 | 2021 |
